Conversion from tacrolimus to neoral in liver and kidney transplant recipients

By Ott R.   Bussenius-Kammerer M.   Scholz D.   Neuhaus R.   Tolba R.H.   Fricke L.   Muller V.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3166-3168

Elsevier

Access to resources Recommend Favorite

Conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients

By Zylber-Katz E.   Doron D.   Granot E.  

Transplantation Proceedings, Vol. 31, Iss. 4, 1999-06 ,pp. : 1915-1917

Elsevier

Access to resources Recommend Favorite

Conversion From Neoral (Cyclosporine) to Tacrolimus of Kidney Transplant Recipients for Gingival Hyperplasia or Hypertrichosis

By Busque S.   Demers P.   St-Louis G.   Boily J.-G.   Tousignant J.   Lemieux F.   Smeesters C.   Corman J.   Daloze P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1247-1248

Elsevier

Access to resources Recommend Favorite

Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus)

By Van Buren D.   Payne J.   Geevarghese S.   MacDonell R.   Chapman W.   Wright J.K.   Helderman J.H.   Richie R.   Pinson C.W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1401-1402

Elsevier

Access to resources Recommend Favorite

Treatment of Cyclosporine-Related Adverse Effects by Conversion to Tacrolimus After Liver Transplantation: Long-Term Results

By Pratschke J.   Neuhaus R.   Tullius S.G.   Jonas S.   Bechstein W.O.   Neuhaus P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1419-1421

Elsevier

Access to resources Recommend Favorite